Cai YW, Shao ZM, Yu KD. De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohort. Cancer 2022 Feb 25. doi: 10.1002/cncr.34155.
PMID: 35213037